Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details)

v3.21.2
Stockholders' Deficit (Details) - USD ($)
 3 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Stockholders' Deficit (Details) [Line Items]    
Preferred stock, shares authorized 50,000,000 50,000,000
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Fair value warrants (in Dollars) $ 64,261  
Restricted Stock, Value, Shares Issued Net of Tax Withholdings (in Dollars) $ 200,000  
Equity Option [Member]    
Stockholders' Deficit (Details) [Line Items]    
Stock option description During the year ended March 31, 2021, the Company issued 25,000 shares of its common stock in connection with the exercise of stock options, with an exercise price of $0.15 per share. During April 2021, the Company received the related proceeds of $3,750.  
Series A Preferred Stock [Member]    
Stockholders' Deficit (Details) [Line Items]    
Preferred stock, shares authorized 300 300
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, share issued 251 251
Preferred stock, share outstanding 251 251
Series B Preferred Stock [Member]    
Stockholders' Deficit (Details) [Line Items]    
Preferred stock, shares authorized 1,500 1,500
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, share issued 1,443 1,443
Preferred stock, share outstanding 1,443 1,443
Series C Preferred Stock [Member]    
Stockholders' Deficit (Details) [Line Items]    
Preferred stock, shares authorized 600,000 600,000
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, share issued 500,756 500,756
Preferred stock, share outstanding 500,756 500,756